VONVENDI (von Willebrand factor (recombinant))
VON WILLEBRAND FACTOR · VON WILLEBRAND'S DISEASE ·+2
BAXALTA US INC.
Drug class
von Willebrand factor
Von Willebrand factor constitutes a therapeutic class of hemostatic replacement biologics that includes plasma-derived concentrates—often formulated in complex with coagulation factor VIII—and recombinant human von Willebrand factor. Read more about von Willebrand factor
1 drugs in this class 1 manufacturers
Drugs in von Willebrand factor
Filter & compare in the drug finder →
Opens the drug finder with von Willebrand factor preselected. Add indication or manufacturer filters there.
Von Willebrand factor constitutes a therapeutic class of hemostatic replacement biologics that includes plasma-derived concentrates—often formulated in complex with coagulation factor VIII—and recombinant human von Willebrand factor.
These agents exert their primary therapeutic role by restoring normal hemostasis, directly mediating platelet adhesion to damaged vascular subendothelium, promoting platelet aggregation, and serving as a stabilizing carrier protein for endogenous factor VIII to prolong its circulatory half-life.
The class is predominantly indicated for the on-demand control of bleeding episodes, perioperative surgical management, and routine bleeding prophylaxis in adult and pediatric patients with von Willebrand disease, as well as selected manifestations of hemophilia A when formulated as a factor VIII complex.
-
fda.gov
Von Willebrand factor constitutes a therapeutic class of hemostatic replacement biologics that includes plasma-derived concentrates—often formulated in complex with coagulation factor VIII—and recombinant human von Willebrand factor These agents exert their primary therapeutic role by restoring normal hemostasis, directly mediating platelet adhesion to damaged vascular subendothelium, promoting platelet aggregation, and serving as a stabilizing carrier protein for endogenous factor VIII to prolo...
-
fda.gov
Von Willebrand factor constitutes a therapeutic class of hemostatic replacement biologics that includes plasma-derived concentrates—often formulated in complex with coagulation factor VIII—and recombinant human von Willebrand factor
-
iatrox.com
Von Willebrand factor constitutes a therapeutic class of hemostatic replacement biologics that includes plasma-derived concentrates—often formulated in complex with coagulation factor VIII—and recombinant human von Willebrand factor These agents exert their primary therapeutic role by restoring normal hemostasis, directly mediating platelet adhesion to damaged vascular subendothelium, promoting platelet aggregation, and serving as a stabilizing carrier protein for endogenous factor VIII to prolo...
-
fda.gov
The class is predominantly indicated for the on-demand control of bleeding episodes, perioperative surgical management, and routine bleeding prophylaxis in adult and pediatric patients with von Willebrand disease, as well as selected manifestations of hemophilia A when formulated as a factor VIII complex
-
fda.gov
The class is predominantly indicated for the on-demand control of bleeding episodes, perioperative surgical management, and routine bleeding prophylaxis in adult and pediatric patients with von Willebrand disease, as well as selected manifestations of hemophilia A when formulated as a factor VIII complex
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.